## Background Psoriasis is a chronic inflammatory skin disease that can be successfully treated with a mixture of fumaric acid esters (FAE) formulated as enteric-coated tablets for oral use. These tablets consist of dimethylfumarate (DMF) and salts of monoethylfumarate (MEF) and its main bioactive
β¦ LIBER β¦
Pharmacokinetics of anti-psoriatic fumaric acid esters in psoriasis patients
β Scribed by Martin Rostami-Yazdi; Bernd Clement; Ulrich Mrowietz
- Book ID
- 106079039
- Publisher
- Springer-Verlag
- Year
- 2010
- Tongue
- English
- Weight
- 325 KB
- Volume
- 302
- Category
- Article
- ISSN
- 0340-3696
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
In vitropharmacokinetics of anti-psoriat
β
Nicolle HR Litjens; Elisabeth van Strijen; Co van Gulpen; Herman Mattie; Jaap T
π
Article
π
2004
π
BioMed Central
π
English
β 515 KB
Fumaric acid esters in the management of
β
L. Brewer; S. Rogers
π
Article
π
2007
π
John Wiley and Sons
π
English
β 436 KB
Fumaric acid esters in the treatment of
β
A.V. Anstey
π
Article
π
2010
π
John Wiley and Sons
π
English
β 50 KB
Treatment of psoriasis with fumaric acid
β
Mrowietz; Christophers; Altmeyer; THE PARTICIPANTS IN THE GERMAN MULTICENTRE STU
π
Article
π
1998
π
John Wiley and Sons
π
English
β 399 KB
Systemic treatment of psoriasis with fumaric acid esters (FAE) has been found effective by empirical means. In recent years clinical studies have confirmed the antipsoriatic activity of a defined mixture of different FAE. The aim of the present prospective multicentre study was to investigate furthe